UncategorizedFDA approves the Cognoa ASD Diagnosis Aid for autism!

FDA approves the Cognoa ASD Diagnosis Aid for autism!

-

Federal regulators authorized a device to help primary care doctors determine whether or not a child has autism. This will allow kids to be diagnosed far sooner, and they will not have to wait long for specialists. The green signal to market the Cognoa ASD Diagnosis Aid was given by the Food and Drug Administration this month, branded Canvas Dx.

An algorithm to analyze data is used by the machine learning-based software submitted by health care providers and parents to return a positive or negative for ASD response for a child. To use the device, caregivers and parents answer questions about behavior and, through a mobile app, submit videos of a child. Through a special portal, the healthcare workers answer questions. Certified specialists review the videos, and the algorithm decides only if sufficient information is provided.

According to Cognoa, it is the first device authorized by the FDA to help primary care physicians diagnose autism which makes the product. The condition of autism could be challenging to diagnose because symptoms vary, the FDA said. As a result, the latest data from CDC shows that the median age for autism diagnosis is older than four even though the developmental disability can be reliably detected by age 2.

The families’ main problem is long waits to see a clinician skilled in evaluating children for autism. The Cognoa aid will solve this problem with less specialized training the tools given to primary care physicians to make a diagnosis themselves. Within a few weeks, that can happen with the device, according to the company.

“Autism spectrum disorder can delay a child’s physical, cognitive and social development, including motor skill development, learning, communication and interacting with others. The earlier ASD can be diagnosed, the more quickly intervention strategies and appropriate therapies can begin,” said Dr. Jeff Shuren, director of the FDA’s Center for Devices and Radiological Health. “Today’s marketing authorization provides a new tool for helping diagnose children with ASD.”

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest news

Bulgarian PM and North Macedonia agrees to redouble efforts to boost battered ties

On Tuesday, the prime ministers of North Macedonia, Dimitar Kovacevski and Bulgaria, Kiril Petkov, agreed to improve the Balkan...

Pope Francis’ aide Cardinal Pietro Parolin tests positive for Covid-19

On Tuesday, a spokesman for the Holy See said that the Vatican’s advisor and top diplomat to Pope Francis,...

Covid-19: Bulgaria sets daily record; around 10,000 citizens tested positive in a day

The situation of Covid-19 is getting worst day by day in Bulgaria. On Tuesday, the nation set a daily...

Bulgarian govt amends travel protocols for red-zoned countries

After a massive protest by the country’s hospitality industry and winter resorts, the health ministry has decided to amend...

Twindemic: Threat returns in EU with surge in Covid-19 and flu cases

The “twindemic” threat in Europe has returned at a faster than expected rate during this winter season. The concerns...

Covid-19: Bulgaria reports 2,379 new cases & 44 deaths in past 24 hrs

According to the statics shared by the unified information portal in January, Bulgaria reported 2,379 new Covid-19 cases out...

Must read

The govt of The Republic of Vanuatu to join hands with FACT to reassess their Citizenship by Investment Programme

Recognizing the significance and impact of the Citizenship by...

Price of Wentworth Estate’s homes to be double by 2024-25

News by ZEBVO: Top-notched amenities are among those things...

You might also likeRELATED
Recommended to you